A competitive nucleic acid sequence-based amplification assay for the quantification of human MDR1 transcript in leukemia cells

Clinica Chimica Acta

Volumn 342, Issue 1-2, 2004, Pages 115-126

  Hayashi, Tsukasa ^a   Kobayashi, Hiroyuki ^b   Miyachi, Hayato ^b   Ohshima, Toshio ^b   Ujiiye, Takeshi ^a   Kawase, Masako ^a   Hotta, Tomomitsu ^b   Takemura, Yuzuru ^c  

^a KAINOS Laboratories Inc   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Leukemia cells; Multidrug resistance 1 gene (MDR1); Nucleic acid sequence based amplification; Reverse transcription polymerase chain reaction

Indexed keywords

BETA ACTIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1;

ACCURACY; ARTICLE; ASSAY; AUTOANALYZER; BLOOD SAMPLING; CANCER PATIENT; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEASIBILITY STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKEMIA CELL; LINEAR SYSTEM; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION;

ACTINS; CHEMILUMINESCENT MEASUREMENTS; HUMANS; LEUKEMIA; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTES; MYELODYSPLASTIC SYNDROMES; P-GLYCOPROTEIN; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELF-SUSTAINED SEQUENCE REPLICATION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 1542394983     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.12.013     Document Type: Article

References (30)

1. Roninson I.B., Chin J.E., Choi K.G.et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 83:1986;4538-4542.
2. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. U. S. A. 84:1987;3004-3008.
3. Campos L., Guyotat D., Archimbaud E.et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood. 79:1992;473-476.
4. Zubercova O., Babusikova O. The multidrug resistance in human leukemias. Neoplasma. 45:1998;53-59.
5. Illmer T., Schuler U.S., Thiede C.et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res. 62:2002;4955-4962.
6. Tafuri A., Gregorj C., Petrucci M.T.et al. MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood. 100:2002;974-981.
7. Beck W.T., Grogan T.M., Willman C.L.et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res. 56:1996;3010-3020.
8. Kawabata M., Kobayashi H., Mori S., Sekiguchi S., Takemura Y. Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells. Rinsho Byori. 45:1997;891-898. [in Japanese with English abstract].
9. Kato S., Ideguchi H., Futata Y.et al. Analysis of mdr-1 gene expression in human leukemic cells by quantitative competitive PCR. Leuk. Lymphoma. 14:1994;129-135.
10. Kobayashi H., Takemura Y., Miyachi H.et al. Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay. J. Clin. Lab. Anal. 11:1997;258-266.
11. Kobayashi H., Takemura Y., Kawai Y.et al. Competitive reverse transcription-polymerase chain reaction assay for quantification of human multidrug resistance 1 (MDR1) gene expression in fresh leukaemic cells. J. Lab. Clin. Med. 135:2000;199-209.
12. Fujimaki S., Funato T., Harigae H.et al. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia. Clin. Chem. 48:2002;811-817.
13. Egashira M., Kawamata N., Sugimoto K., Kaneko T., Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood. 93:1999;599-606.
14. Lohri A., van Hille B., Reuter J., Tichelli A., Herrmann R. mRNA expression, measured by quantitative reverse transcriptase polymerase chain reaction, of five putative drug resistance parameters, in normal and leukaemic peripheral blood and bone marrow. Acta Haematol. 98:1997;1-7.
15. Drach J., Zhao S., Drach D., Korbling M., Engel H., Andreeff M. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis. Leuk. Lymphoma. 16:1995;419-424.
16. Licht T., Pastan I., Gottesman M., Herrmann F. P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann. Hematol. 69:1994;159-171.
17. Klimecki W.T., Futscher B.W., Grogan T.M., Dalton W.S. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood. 83:1994;2451-2458.
18. Chaudhary P.M., Mechetner E.B., Roninson I.B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 80:1992;2735-2739.
19. Drach D., Zhao S., Drach J.et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood. 80:1992;2729-2734.
20. Marie J.P., Brophy N.A., Ehsan M.N.et al. Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells. Br. J. Haematol. 81:1992;145-152.
21. Tong J., Bendahhou S., Chen H., Agnew W.S. A simplified method for single-cell RT-PCR that can detect and distinguish genomic DNA and mRNA transcripts. Nucleic Acids Res. 22:1994;3253-3254.
22. Chandler D.P., Wagnon C.A., Bolton H. Jr. Reverse transcriptase (RT) inhibition of PCR at low concentrations of template and its implications for quantitative RT-PCR. Appl. Environ. Microbiol. 64:1998;669-677.
23. Compton J. Nucleic acid sequence-based amplification. Nature. 350:1991;91-92.
24. Kievits T., van Gemen B., van Strijp D.et al. NASBA™ isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods. 35:1991;273-286.
25. Heim A., Grumbach I.M., Zeuke S., Top B. Highly sensitive detection of gene expression of an intronless gene: amplification of mRNA, but not genomic DNA by nucleic acid sequence based amplification (NASBA). Nucleic Acids Res. 26:1998;2250-2251.
26. Simpkins S.A., Chan A.B., Hays J., Pöpping B., Cook N. An RNA transcription-based amplification technique (NASBA) for the detection of viable Salmonella enterica. Lett. Appl. Microbiol. 30:2000;75-79.
27. Arkin H., Ohnuma T., Kamen B.A., Holland J.F., Vallabhajosula S. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Cancer Res. 49:1989;6556-6561.
28. Yoshimoto M. Automated chemiluminescent DNA probe assay system. Jpn. J. Clin. Lab. Automation. 20:1995;3728-3731. [in Japanese].
29. Fukahori S. Quantification of WT1 mRNA by competitive NASBA in AML patients. Kurume Med. J. 48:2001;129-134.
30. Suzuki T., Higgins P.J., Crawford D.R. Control selection for RNA quantitation. BioTechniques. 29:2000;332-337.